EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON BLOOD RHEOLOGY OF RAT

被引:0
|
作者
MAEDA, N [1 ]
SHIGA, T [1 ]
机构
[1] OSAKA UNIV,SCH MED,DEPT PHYSIOL,SUITA,OSAKA 565,JAPAN
来源
CLINICAL HEMORHEOLOGY | 1994年 / 14卷 / 01期
关键词
ERYTHROPOIETIN (RECOMBINANT HUMAN); RED CELL DEFORMABILITY; RED CELL AGGREGATION; VISCOSITY; ORGANIC PHOSPHATES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recombinant human erythropoietin (rhEPO; 180 or 1800 IU per kg) was daily administered to 6 weeks old rats for 1 to 2 weeks. [1] The increase of blood viscosity in rhEPO-administered rats in a saturation manner entirely depends on the hematocrit (the plasma viscosity and the plasma protein composition were not altered by rhEPO-administration). [2] No change in red cell deformability was observed upon rhEPO administration. [3] The velocity of rouleaux formation in autologous plasma decreased in rhEPO-administered rats. [4] A considerable polycythemia with reticulocytosis was induced in dose- and duration-dependent manners but in a saturation manner: cell volume increased and intracellular hemoglobin concentration inversely decreased. The density distribution of red cells shifted towards low specific gravity and became heterogenous. [5] No drastic alterations in contents of 2,3-diphosphoglycerate and ATP were detected. In conclusion, the increase of blood viscosity upon daily administration of rhEPO was hematocrit-dependent, regardless of the appearance of red cells with large volume and low internal viscosity.
引用
收藏
页码:53 / 62
页数:10
相关论文
共 50 条
  • [1] METABOLISM OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE RAT
    SPIVAK, JL
    MOLECULAR BIOLOGY OF ERYTHROPOIESIS, 1989, 271 : 29 - 38
  • [2] CHANGES IN DETERMINANTS OF BLOOD RHEOLOGY DURING TREATMENT WITH HEMODIALYSIS AND RECOMBINANT-HUMAN-ERYTHROPOIETIN
    KOPPENSTEINER, R
    STOCKENHUBER, F
    JAHN, C
    BALCKE, P
    MINAR, E
    EHRINGER, H
    BMJ-BRITISH MEDICAL JOURNAL, 1990, 300 (6740): : 1626 - 1627
  • [3] RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR AUTOLOGOUS BLOOD DONATION
    NONOGUCHI, H
    ABE, K
    KOMATSU, F
    LANCET, 1992, 339 (8807): : 1483 - 1483
  • [4] EFFECT OF HEMODIALYSIS AND RECOMBINANT-HUMAN-ERYTHROPOIETIN ON DETERMINANTS OF BLOOD-VISCOSITY
    SHAND, BI
    BUTTIMORE, AL
    LYNN, KL
    BAILEY, RR
    ROBSON, RA
    RENAL FAILURE, 1994, 16 (03) : 407 - 413
  • [5] EFFECT OF LIDOCAINE ON THE HEMATOPOIETIC PROPERTIES OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN THE UREMIC RAT
    KAPLAN, RA
    ALLEN, S
    WARADY, BA
    ALON, US
    PEDIATRIC NEPHROLOGY, 1994, 8 (04) : 477 - 479
  • [6] THE EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AS ADJUVANT TREATMENT FOR AUTOLOGOUS BLOOD DONATION
    GRAF, H
    WATZINGER, U
    LUDVIK, B
    HOCKER, P
    ZWEYMULLER, K
    CLINICAL RESEARCH, 1990, 38 (02): : A538 - A538
  • [7] PHARMACOKINETICS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN
    SINYUKHIN, VN
    STETSYUK, YA
    LOVCHINSKY, YV
    LEBEDEV, SV
    YARMOLINSKY, IS
    LYAKHOV, VV
    TERAPEVTICHESKII ARKHIV, 1994, 66 (08) : 60 - 62
  • [8] ALUMINUM INTOXICATION IN THE RAT INDUCES PARTIAL RESISTANCE TO THE EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN
    LOSEKANN, A
    URENA, P
    KHIRAOUI, F
    CASADEVALL, N
    ZINS, B
    BERERHI, L
    ZINGRAFF, J
    BOURDON, R
    DRUEKE, T
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 (04) : 258 - 263
  • [9] THE USES OF RECOMBINANT-HUMAN-ERYTHROPOIETIN
    PATTERSON, KG
    SAUDI MEDICAL JOURNAL, 1994, 15 (01) : 1 - 13
  • [10] EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON HUMAN IGE PRODUCTION INVITRO
    KIMATA, H
    YOSHIDA, A
    ISHIOKA, C
    MIKAWA, H
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1991, 83 (03): : 483 - 487